| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.008 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.4 | 0.008 |